Corvus Pharmaceuticals Inc (CRVS) short interest & short volume · 24.7% of float short
Corvus Pharmaceuticals Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.
What changed
CRVS short interest was little changed at 18.0M shares in the Oct 15, 2026 report (24.7% of float, 14.9 days to cover). Daily short volume averaged 54.8% of volume over the last 20 sessions, down from 56.6% the 20 sessions before, the 61st percentile of its own 20-day averages since Sep 23, 2025.
Short interest
Official, twice monthly · settled Oct 15, 2026
- Shares short
- 18.0M
- prior 17.8M
- % of float
- 24.7%
- float 72.8M
- Days to cover
- 14.9
- avg vol 1.2M
- Change vs prior report
- +1.0%
Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.
% of float uses the current float for every report (no float was stored with older reports).
Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026
Daily short volume
Share of each day's volume sold short · FINRA Reg SHO
- Latest (Nov 2)
- 65.2%
- 143K of 219K
- 20-day average
- 54.8%
- prior 56.6%
- Percentile vs own history
- 61st
- 233 periods since 2025
Loading prices…
Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026
Short squeeze score (model)
Price since settlement: -0.2%
Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.
CRVS's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr
Market-wide: most shorted stocks, biggest changes and unusual short volume · CRVS overview
| Date | Short | Total | Short % of volume |
|---|---|---|---|
| 2026-11-02 | 142,940 | 219,403 | 65.2% |
| 2026-10-30 | 154,935 | 287,316 | 53.9% |
| 2026-10-29 | 160,180 | 268,671 | 59.6% |
| 2026-10-28 | 144,528 | 290,891 | 49.7% |
| 2026-10-27 | 218,970 | 382,837 | 57.2% |
| 2026-10-26 | 177,708 | 316,720 | 56.1% |
| 2026-10-23 | 229,252 | 352,708 | 65.0% |
| 2026-10-22 | 269,648 | 407,031 | 66.3% |
| 2026-10-21 | 186,505 | 305,896 | 61.0% |
| 2026-10-20 | 189,371 | 347,108 | 54.6% |
Healthcare peers with similar quant ratings
CRVS is rated 1.55 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- DNA short interest1.58 · Sell
- SRRK short interest1.58 · Sell · stock
- JBIO short interest1.57 · Sell · stock
- RAPP short interest1.56 · Sell · stock
- ACRS short interest1.54 · Sell · stock
- ARCT short interest1.54 · Sell · stock
- ADAG short interest1.53 · Sell
- BIOA short interest1.52 · Sell · stock
CRVS short interest FAQ
What is CRVS's short interest?
Corvus Pharmaceuticals Inc (CRVS) had 18.0M shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 24.7% of its 72.8M-share float.
How many days to cover does CRVS have?
14.9 days: 18.0M shares short divided by an average daily volume of 1.2M for the Oct 15, 2026 period.
Is CRVS short interest rising or falling?
CRVS short interest was little changed (+1.0%) from 17.8M to 18.0M shares in the Oct 15, 2026 report.
Is CRVS a short squeeze candidate?
Lician's squeeze watch scores CRVS 58 out of 100 (elevated) from the Oct 15, 2026 report: short interest % of float 32.9/40, days to cover 25/25, change in short interest vs prior report 0.3/15, price change since settlement date 0/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.
What share of CRVS daily volume is sold short?
54.8% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 61st percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.
What was CRVS's latest FINRA short volume?
On Nov 2, 2026, cached FINRA short volume for Corvus Pharmaceuticals Inc (CRVS) was 142,940 shares, 65.2% of 219,403 total volume.
How many CRVS short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Corvus Pharmaceuticals Inc (CRVS), from Oct 20, 2026 through Nov 2, 2026.
How did CRVS short volume percent change from the prior cached session?
Cached FINRA short volume for Corvus Pharmaceuticals Inc (CRVS) moved from 53.9% on Oct 30, 2026 to 65.2% on Nov 2, 2026, up 11.3 percentage points.
Not investment advice. Figures as filed or reported, not a live feed.